Migraines are common yet misunderstood, therefore it is important that various treatment options be examined and offered to this patient population.
Emilie Parkman, PharmD Candidate
Advertisement
Articles by Emilie Parkman, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Blenrep Receives FDA Approval for Treatment of Relapsed or Refractory Multiple Myeloma
2
Elinzanetant Demonstrates Rapid and Sustained Efficacy in Reducing Vasomotor Symptoms Across OASIS Clinical Trials
3
G-CSF is a Potential Alternative in Treatment of Hot Flashes in Postmenopausal Women
4
CHEST 2025: Advancing Respiratory Virus Vaccines and Improving Uptake Among High-Risk Populations
5
